Blood Center rezoning on Upper East Side approved

Proposed 600,000-square-foot campus will get City Council consideration

New York /
Sep.September 23, 2021 11:00 AM
Longfellow Real Estate Partners CEO Adam Sichol with renderings of 310 East 67th Street (Friends UES, Rendering by DBOX, Longfellow)

Longfellow Real Estate Partners CEO Adam Sichol with renderings of 310 East 67th Street (Friends UES, Rendering by DBOX, Longfellow)

A controversial plan to expand the New York Blood Center in the Upper East Side has advanced through the City Planning Commission.

The commission voted 8-to-2 in favor of rezoning for the Center East project. The City Council will consider the proposal for the 600,000-square-foot life science hub, according to Real Estate Weekly.

The Blood Center, located at 310 East 67th Street, is aiming to build a state-of-the-art facility that will play a major part in the city’s life science innovation. The three-story headquarters would be replaced by a 334-foot building.

New facilities would serve as offices and labs for the Blood Center, as well as for other life science firms and medical partners.

“Our vision for a state-of-the-art life science facility will not only ensure the nonprofit Blood Center continues to provide safe, affordable blood services to the region’s hospitals, but enable the center to significantly expand its life-saving research on COVID-19 and blood-related diseases in collaboration with institutions and biotechnology partners all under the same roof,” said Rob Purvis, an executive vice president with the Blood Center.

The hub is being developed with Longfellow Real Estate Partners.

The project is facing some fierce pushback, including City Council member Ben Kallos and the community around the Blood Center.

A major point of contention has been the size of the building, which prompted the rezoning proposal through the ULURP process. The maximum height of buildings in the area is 75 feet high, meaning the proposed tower would more than quadruple that mark. The proposed height sparked complaints the building could cast shadows over a nearby school and park.

Another point of criticism focused on the perceived lack of transparency surrounding the facility’s potential work. The lab is expected to process microbes “indigenous or exotic, and they can cause serious or potentially lethal disease through respiratory transmission,” according to the CDC.

[REW] — Holden Walter-Warner





    Related Articles

    arrow_forward_ios
    Terra Capital's Vik Uppal, RedSky's Benjamin Bernstein with 658 Driggs Avenue and 625 Driggs Avenue (Terra, ICSC, StreetEasy)
    RedSky founders accused of failing to repay bailout
    RedSky founders accused of failing to repay bailout
    A photo illustration of Related Companies' Jeff Blau (Getty)
    Related proposes 1,500-room resort in Hudson Yards casino bid
    Related proposes 1,500-room resort in Hudson Yards casino bid
    Jared Kushner and 666 Fifth Avenue (Getty, David Shankbone, CC BY 2.5 - via Wikimedia Commons)
    Congress probes Jared Kushner’s dealings amid 666 Fifth Avenue sale
    Congress probes Jared Kushner’s dealings amid 666 Fifth Avenue sale
    (Getty)
    The conspiracy theories plaguing real estate
    The conspiracy theories plaguing real estate
    Jonathan Landau
    Jonathan Landau leaves Fortis to launch firm
    Jonathan Landau leaves Fortis to launch firm
    Council member Pierina Ana Sanchez and RSA’s Joseph Strasburg (Getty; Twitter)
    Citing Bronx fire, Council pushes building violation crackdown
    Citing Bronx fire, Council pushes building violation crackdown
    SB Development’s Joseph Stern and Northwind’s Ran Eliasaf with rendering of Nova (LinkedIn, NOVA)
    SB Development, Hazelton Capital score $62M loan for LIC condo tower
    SB Development, Hazelton Capital score $62M loan for LIC condo tower
    Illustration of Mayor Eric Adams (Getty; Illustration by Kevin Rebong for The Real Deal)
    Oh, rats! Eric Adams contests summons for infestation
    Oh, rats! Eric Adams contests summons for infestation
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...